145 related articles for article (PubMed ID: 18662130)
1. Effect of pretreatment with toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis.
Boivin N; Sergerie Y; Rivest S; Boivin G
J Infect Dis; 2008 Sep; 198(5):664-72. PubMed ID: 18662130
[TBL] [Abstract][Full Text] [Related]
2. Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis.
Boivin N; Menasria R; Piret J; Boivin G
Antiviral Res; 2012 Dec; 96(3):414-21. PubMed ID: 23043942
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.
Ashkar AA; Yao XD; Gill N; Sajic D; Patrick AJ; Rosenthal KL
J Infect Dis; 2004 Nov; 190(10):1841-9. PubMed ID: 15499542
[TBL] [Abstract][Full Text] [Related]
4. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
5. CCAAT/enhancer binding protein-alpha is down-regulated by toll-like receptor agonists in microglial cells.
Ejarque-Ortiz A; Tusell JM; Serratosa J; Saura J
J Neurosci Res; 2007 Apr; 85(5):985-93. PubMed ID: 17253645
[TBL] [Abstract][Full Text] [Related]
6. CpG and poly(I:C) stimulation of dendritic cells and fibroblasts limits herpes simplex virus type 1 infection in an IFNβ-dependent and -independent way.
Gaajetaan GR; Geelen TH; Grauls GE; Bruggeman CA; Stassen FR
Antiviral Res; 2012 Jan; 93(1):39-47. PubMed ID: 22057305
[TBL] [Abstract][Full Text] [Related]
7. Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice.
Sergerie Y; Boivin G; Gosselin D; Rivest S
J Infect Dis; 2007 Mar; 195(6):817-25. PubMed ID: 17299711
[TBL] [Abstract][Full Text] [Related]
8. Profile of Toll-like receptor expressions and induction of nitric oxide synthesis by Toll-like receptor agonists in chicken monocytes.
He H; Genovese KJ; Nisbet DJ; Kogut MH
Mol Immunol; 2006 Mar; 43(7):783-9. PubMed ID: 16098593
[TBL] [Abstract][Full Text] [Related]
9. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
10. Role of IFN-alpha/beta signaling in the prevention of genital herpes virus type 2 infection.
Svensson A; Bellner L; Magnusson M; Eriksson K
J Reprod Immunol; 2007 Jun; 74(1-2):114-23. PubMed ID: 17092567
[TBL] [Abstract][Full Text] [Related]
11. Potential role of toll-like receptor 3 in a murine model of polyinosinic-polycytidylic acid-induced embryo resorption.
Lin Y; Zeng Y; Zeng S; Wang T
Fertil Steril; 2006 Apr; 85 Suppl 1():1125-9. PubMed ID: 16616084
[TBL] [Abstract][Full Text] [Related]
12. Synergy of CpG oligodeoxynucleotide and double-stranded RNA (poly I:C) on nitric oxide induction in chicken peripheral blood monocytes.
He H; Genovese KJ; Nisbet DJ; Kogut MH
Mol Immunol; 2007 May; 44(12):3234-42. PubMed ID: 17339052
[TBL] [Abstract][Full Text] [Related]
13. Microglia activation in rat spinal cord by systemic injection of TLR3 and TLR7/8 agonists.
Zhang Z; Trautmann K; Schluesener HJ
J Neuroimmunol; 2005 Jul; 164(1-2):154-60. PubMed ID: 15904976
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysacchride-treated mammary carcinomas secrete proinflammatory chemokines and exhibit reduced growth rates in vivo, but not in vitro.
Nair P; O'Donnell CM; Janasek K; Sajduk MK; Smith EA; Golden JM; Vasta CA; Huggins AB; Kurt RA
Immunol Invest; 2009; 38(8):730-48. PubMed ID: 19860585
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis.
Sergerie Y; Rivest S; Boivin G
J Infect Dis; 2007 Sep; 196(6):853-60. PubMed ID: 17703415
[TBL] [Abstract][Full Text] [Related]
16. Activation of toll-like receptors 2 or 3 and preterm delivery in the mouse.
Ilievski V; Lu SJ; Hirsch E
Reprod Sci; 2007 May; 14(4):315-20. PubMed ID: 17644803
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of human female primary genital epithelial cells to herpes simplex virus, type-2 and the effect of TLR3 ligand and sex hormones on infection.
MacDonald EM; Savoy A; Gillgrass A; Fernandez S; Smieja M; Rosenthal KL; Ashkar AA; Kaushic C
Biol Reprod; 2007 Dec; 77(6):1049-59. PubMed ID: 17881767
[TBL] [Abstract][Full Text] [Related]
18. [Protective effects of trichosanthin in Herpes simplex virus-1 encephalitis in mice].
Chen GF; Huang WG; Chen FY; Shan JL
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):239-41. PubMed ID: 16787600
[TBL] [Abstract][Full Text] [Related]
19. Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women.
Nazli A; Yao XD; Smieja M; Rosenthal KL; Ashkar AA; Kaushic C
Antiviral Res; 2009 Feb; 81(2):103-12. PubMed ID: 19013198
[TBL] [Abstract][Full Text] [Related]
20. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
